Severe Acquired Brain Injuries: Prognostic Factors and Quality of Care

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMario Negri Institute for Pharmacological Research

About this trial

The main purpose of this project is to identify the medium-term prognostic factors for patients with Severe Acquired Brain Injuries and evaluate their impact.

The secondary aim is to create a system of continuous assessment of the quality of care for each rehabilitation unit.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

patients with Serious Acquired Brain Injuries

admission to rehabilitation units

Disqualifiers

None

Trial population

All patients admitted in the Rehabilitation Units for Severe Acquired Brain Injuries participating in the study during the 30 months of enrollment provided by the research

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

2,500 Participants
are grouped into 1 trial group
Group A: Adults admitted in participating Rehabilitation Units for Severe Acquired Brain Injuries

Trial outcomes

Primary outcomes

1

Tracheostomy tube

Removal of the tracheostomy tube, which is considered successful if the patient is not to be re-cannulated within 7 days

Time frame
july 2021 - june 2025
2

Trunk control

Achievement of trunk control, for which the patient must be able to maintain the sitting position for at least 60 seconds, on a rigid surface, with the lower limbs in support, but without support from the upper limbs and without rear support of the trunk

Time frame
july 2021 - june 2025
3

Total feeeding by os

Oral feeding with sufficient caloric intake

Time frame
july 2021 - june 2025

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.